• Fatty liver disease 'does not increase risk of death'

    Solid phase extraction (SPE)

    Fatty liver disease 'does not increase risk of death'

    Non-alcoholic fatty liver disease (NAFLD) does not affect the long-term survival of sufferers, as previously thought, according to new research.

    Scientists at John Hopkins School of Medicine successfully used solid phase extraction data to assess enzyme and substrate levels associated with NAFLD in over 11,000 patients.

    The findings, published in the British Medical Journal, show no increase in mortality among those diagnosed with NAFLD, which was identified in around 20 per cent of the participants.

    Study leader Mariana Lazo explained that the data did not show NAFLD to be a risk factor for cardiovascular disease.

    "We were surprised to say the least because we expected to learn by how much non-alcoholic fatty liver disease increased the risk of death and instead found the answer was not at all," she added.

    However, Ms Lazo indicated further research would be needed to determine if advanced variations of the condition pose more serious consequences.

    Posted by Fiona Griffiths


    Events

    SETAC Europe

    May 11 2025 Vienna, Austria

    MSB 2025

    May 18 2025 Tempe. AZ, USA

    ChemUK 2025

    May 21 2025 Birmingham, UK

    ASMS Conference

    Jun 01 2025 Baltimore, MD, USA

    HPLC 2025

    Jun 15 2025 Bruges, Belgium

    View all events

    Great Job...
    The latest issue will be with you shortly
    Sign up to Chromatography Today for FREE.
    Register and get the eBulletin, a Monthly email packed with the latest Chromatography products, news and services. Join us and get the latest information first.